Professor Hiroaki Suga is internationally recognised for his ground-breaking work developing RNA-based catalysts that facilitate a new method for discovering bioactive peptides. His work involves replicating the processes of the ribosome in the laboratory to allow for artificial peptide and protein translation. His RNA catalyst, the flezixyme, allows unnatural amino acids to be incorporated into peptides and proteins, a revolutionary development that enables the production of a huge variety of molecules that could not be created in nature. Using the power of the flexizyme, Professor Suga developed RaPID, an innovative platform that facilitates the screening of billions of peptides against a protein target to find binders. RaPID is now widely used around the world to find potential drugs for important protein targets.